Day: December 7, 2020

WATERTOWN, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel, small molecule protein degrader therapeutics, today announced the company presented preclinical data that further support development of its highly selective and potent IRAKIMiD and STAT3 protein degraders scheduled to enter the clinic in 2021. Data were presented at the virtual 62nd American Society of Hematology (ASH) Annual Meeting, Dec. 5-8, 2020 in three separate poster presentations.IRAKIMiD ProgramABSTRACT #2088, “KTX-120, A Novel IRAKIMiD Degrader of IRAK4 and IMiD Substrates, Shows Preferential Activity and Induces Regressions in MYD88-Mutant DLBCL Cell and Patient Derived Xenograft Models,” presented by Duncan H. Walker, PhD, Vice President of...

ATLANTA and PORTLAND, Ore., Dec. 07, 2020 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the market leader in cloud business management solutions, and GCPay, the leading web-based platform for managing the subcontractor pay application process, today announced a strengthened partnership. Sage will now offer GCPay as an add-on with its industry-leading construction solutions, Sage 300 Construction and Real Estate and Sage 100 Contractor.“Managing subcontractor invoicing and payment processes is a source of frustration for many construction firms,” said Dustin Anderson, vice president of Sage Construction and Real Estate. “It usually entails back and forth emails or calls to address issues such as incorrect billings, unapproved change orders, missing lien waivers, or expired compliance documents. Our partnership with GCPay helps to eliminate...

Pièce jointe2020 11 30 Droits de vote

STAMFORD, Conn., Dec. 07, 2020 (GLOBE NEWSWIRE) — Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study examining service providers that support the modernization, transformation and use of mainframe computers in enterprise settings.The study results will be published in a comprehensive ISG Provider Lens™ report, called Mainframe Services & Solutions, scheduled to be released in April. The report will cover vendors that offer mainframe transformation and application modernization services as well as mainframe-as-a-service and storage-as-a-service offerings.Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information...

ISELIN, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ:MSEX) announced today that its Chairman, President and CEO Dennis W. Doll will be among water industry leaders presenting at the BofA Securities 2020 Virtual Water Conference on Thursday, December 10, 2020. Mr. Doll’s remarks are expected to include an overview of the Company’s financial performance and operational highlights, comments on consistent service delivery during the pandemic, progress on the largest capital program in the company’s history and its expanded commitment to Environmental, Social and Governance oversight and disclosure. The event will bring together water industry leadership, regulators, investors and other key industry stakeholders for an in depth discussion on the state of the water industry, sustainable infrastructure investing...

SAN FRANCISCO, Dec. 07, 2020 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced the presentation of key preclinical data from its lead program, NX-2127, for the potential treatment of B-cell malignancies, at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition. Supported by these data, Nurix plans to initiate a Phase 1 clinical trial of orally administered NX-2127 in patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) in the first half of 2021.“The data presented at ASH demonstrate the unique dual properties of NX-2127 which is designed to overcome treatment failures including resistance to approved agents while simultaneously activating additional cancer-fighting...

AFM13 monotherapy was well tolerated and reached an Objective Response Rate of 42 percent among heavily pretreated patients with R/R CD30-positive lymphoma with cutaneous presentationImmunological analyses revealed that innate cell engagers modulate NK and T cell populations in peripheral blood and tumorsHeidelberg, Germany, December 7, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the presentation of a clinical data set on AFM13 at the 62nd American Society of Hematology Annual Meeting and Exposition. Dr. Ahmed Sawas, Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons and the New York-Presbyterian Hospital, and principal investigator presented the updated results of a phase 1b/2a...

OMER, Israel, Dec. 07, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq:MDGS) (TASE:MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it was informed by Smart Repair Pro, Inc. a data-driven e-commerce company operating on the Amazon Marketplace, that all of Amazon’s required regulatory processes were completed, which allows for the opening of its store in Singapore. Following Amazon’s approval, Smart Repair Pro is preparing to launch its brands for the first time in these two countries. Smart Repair Pro has already received Amazon’s approval to launch in Australia, the United Kingdom and four leading countries in Europe and operates in the U.S. today.Medigus recently announced it intends to enter into e-commerce business by signing a definitive agreement to acquire...

Jinhua, China, Dec. 07, 2020 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (the “Company” or “Kandi”) today issued a letter to its shareholders from the Chairman as below:Dear Kandi Shareholder,On November 30, 2020, a firm with an acknowledged short position in Kandi stock issued a “research report” that leveled a series of inaccurate allegations regarding Kandi and its management team.  The firm that issued the report is shorting our stock and will profit if the stock price declines.  In contrast, the Company’s motive is to create value for all shareholders by building a durable and profitable leader in a dynamic growth industry.   It is clear from this review that the report contains a variety of misleading accusations that are either thinly veiled assertions of opinion, or based on previously reported historical...

Fireside Chat to Be Held on Tuesday, December 8, 2020, at 11:00 am ET.Miami Beach, FL, Dec. 07, 2020 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner and operator of electric vehicle (EV) charging equipment and services, will be participating in the Water Tower Research Virtual Conference and Fireside Chat Series on Tuesday, December 8, 2020, at 11:00 am ET. Topics covered by Mr. Brendan Jones, Blink’s Chief Operating Officer, and moderated by Mr. Shawn Severson, Head of Sustainable Investing at Water Tower Research, will be centered around the Company’s operations. Mr. Jones will provide an update on the Company’s operations and further describe its plans for the recent acquisitions of U-Go Stations Inc. and BlueLA Carsharing LLC.Investors interested in participating in this...